China Universal Asset Management Co., Ltd. Syndax Pharmaceuticals Inc Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 16,367 shares of SNDX stock, worth $229,138. This represents 0.04% of its overall portfolio holdings.
Number of Shares
16,367
Previous 9,984
63.93%
Holding current value
$229,138
Previous $204,000
54.41%
% of portfolio
0.04%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding SNDX
# of Institutions
231Shares Held
90MCall Options Held
1.01MPut Options Held
692K-
Black Rock Inc. New York, NY7.91MShares$111 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.84MShares$81.8 Million9.23% of portfolio
-
Wellington Management Group LLP Boston, MA4.99MShares$69.8 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$68.4 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.11MShares$57.5 Million6.25% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $792M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...